Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > CRIXlabs Joins the ROCK Health Incubator: ROCK Health is the world’s leading healthcare incubator looking to make meaningful change through scalable, innovative technology.

Abstract:
CRIXlabs, Inc. today announced joining the ROCK Health incubator located in San Francisco, CA. CRIXlabs is the creator of NuSilico, the #1 predictive nanoparticle software used by Pharma.

CRIXlabs Joins the ROCK Health Incubator: ROCK Health is the world’s leading healthcare incubator looking to make meaningful change through scalable, innovative technology.

San Diego, CA | Posted on June 5th, 2013

"We couldn't be more excited to be part of the family over at ROCK Health" said Jon Stenstrom, CRIXlabs' CEO and Co-Founder. "CRIXlabs' NuSilico software enables pharmaceutical companies to create more effective treatments with reduced side-effects, for cancer and a wide variety of other diseases." Jon has a strong healthcare product development background and holds a Master of Engineering from San Diego State University.

The CRIXlabs team includes Dr. Shalini Ananda, CTO and Co-Founder with expertise in software development and nanotechnology and Dr. Garrett Smith, Co-Founder and advisor, a serial entrepreneur with expertise in nanoparticle synthesis and a former Stanford BioDesign Fellow; both of which received their PhDs from the University of California, San Diego.

The ROCK Health announcement: rockhealth.com/2013/06/new-class-new-partners-new-space/

####

About CRIXlabs, Inc.
Creators of NuSilico, the #1 predictive nanoparticle software used by Pharma.

NuSilico increases the probability of finding the next blockbuster drug. Today, Pharma uses NuSilico to identify unfavorable nanotherapeutic candidates early, potentially saving years of development time and millions of dollars. NuSilico can optimize nanoparticle platforms, increasing their ability to treat diseases such as cancer more effectively and with lower side-effects.

CRIXlab’s unique background in software, nanoparticle synthesis, and imaging helps researchers look at all possible scenarios prior to beginning pre-clinical trials.

NuSilico uses a proprietary database and algorithms to determine the biodistribution and half-life of nanoparticle platforms prior to expensive preclinical trials. Early identification helps ensure the research process is efficient and cost-effective for the client.

CRIXlabs has been accepted into the ROCK Health incubator in San Francisco and have terms on the table with Kleiner Perkins, Mohr Davidow, Aberdare Ventures, and the Mayo Clinic.

They have begun working with a Top 10 Pharmaceutical company on their nanoparticle platforms. They are in active discussions with the Top 5 Pharmaceutical companies for the use of their software.

For more information, please click here

Contacts:
Jon Stenstrom, MEng.
Co-Founder & CEO
CRIXlabs, Inc.
858-598-4272

Copyright © CRIXlabs, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Switching to spintronics: Berkeley Lab reports on electric field switching of ferromagnetism at room temp December 17th, 2014

ORNL microscopy pencils patterns in polymers at the nanoscale December 17th, 2014

Unraveling the light of fireflies December 17th, 2014

First Home-Made Edible Herbal Nanodrug Presented to Pharmacies across Iran December 17th, 2014

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

Pixelligent Closes $5.5 Million in Funding: Capital Will Be Used to Support Global Customer Growth December 12th, 2014

Eight19 secures £1m funding: Investment to develop production technology, and expand commercial activities for organic photovoltaics November 19th, 2014

Harris & Harris Group Reports Financial Statements as of September 30, 2014 November 11th, 2014

Harris & Harris Group to Host Conference Call on Third Quarter 2014 Financial Results on November 12, 2014 November 3rd, 2014

Software

Spectral Surface Mapping with Microscopic Resolution: CRAIC Technologies introduces Spectral Surface Mapping™ (S2M™) software November 18th, 2014

FEI Releases New Electronics Failure Analysis Applications for Helios NanoLab DualBeam Portfolio: Dx gas chemistry enables rapid delayering of ICs, while AutoLX advanced automation simplifies sample preparation for transmission electron microscopy November 3rd, 2014

Announcements

Switching to spintronics: Berkeley Lab reports on electric field switching of ferromagnetism at room temp December 17th, 2014

ORNL microscopy pencils patterns in polymers at the nanoscale December 17th, 2014

Unraveling the light of fireflies December 17th, 2014

First Home-Made Edible Herbal Nanodrug Presented to Pharmacies across Iran December 17th, 2014

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE